the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Busulfan Fresenius Kabi intended for conditioning treatment prior to conventional ... European Medicines Agency, 5 days ago
Xultophy, Accofil and Busulfan recommended by EMA/CHMP - Pharma Letter, 4 days ago
News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 July 2014 - European Medicines Agency, 5 days ago
Approval has been recommended for 2 new generic drugs that can be used in cancer treatment in the European Union, as has an expanded indication for a third drug. Marketing authorization has been recommended by the Committee for Medicinal Products ...American Journal of Public Health, 2 days ago
Sebi had declined monetary settlement of charges of Rs 500-cr unlawful gains BS Reporters | Mumbai July 1, 2014 Last Updated at 00:59 IST The Securities Appellate Tribunal ( SAT) on Monday dismissed an appeal by Reliance Industries Ltd (RIL) against ...Business Standard India, 4 weeks ago
Aurobindo Pharma Ltd. et al.; Withdrawal of Approval of Eighty-Six Abbreviated New Drug Applications
Notice. Citation: "79 FR 35170" Document Number: "Docket No. FDA-2014-N-0662" Page Number: "35170" "Notices" SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 86 abbreviated new drug applications (ANDAs) from ...Pharmacy Choice, 1 month ago
on your WebpageAdd Widget >Get your members hooked!